Fig. 5From: Identification of RASSF1A promoter hypermethylation as a biomarker for hepatocellular carcinomaKaplan-Meier survival and time‐dependent ROC curves of different RASSF1A methylation statuses in the TCGA HCC cohort. a, b Prognostic influences of the promoter hypermethylation of RASSF1A on OS and DFS in the TCGA cohort; c, d Time-dependent ROC curve analysis of the predictive power of RASSF1A methylation statuses on OS and DFSBack to article page